Back to search

Sweden· SE-20040607001769

Glucomed 625 mg Tablett

A medicinal product containing glucosamine hydrochloride, registered in Sweden by Laboratoires Expanscience.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedGlucomed 625 mg TablettATC—REGISTER NO.SE-20040607001769PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Glucosamine Hydrochloride
Manufacturer
Laboratoires Expanscience
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20040607001769

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Glucosamine hydrochloride in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glucosamine hydrochloride products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Cyprus · Donarthril
  • Czechia · Artaxin, Flexove
  • Germany · Glucosamin Doppelherzpharma
  • Spain · Acenam, Duartron
  • Finland · Glucosamin Orion
  • France · Flexea, Osaflexan
  • United Kingdom (Northern Ireland) · Glucosamine Medley Pharma, Yointy
  • Greece · Donarot, Energorot
  • Hungary · Cartilamin, Glukozamin Pharma Nord
  • Ireland · Arthrimel, Dona
  • Iceland · Glucomed
  • Norway · Glucosamin Orifarm, Samin
  • Poland · Flexove
  • Portugal · Biartril, Glucomed
  • Slovakia · Glucomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4e78722c-f199-4d92-bf6b-543e56404cdf
GET /v1/drugs/4e78722c-f199-4d92-bf6b-543e56404cdf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC",
    "PAR"
  ],
  "se_npl_id": "20040607001769",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20040607001769",
  "product_doc_link": "https://docetp.mpa.se/LMF/Glucomed%20tablet%20ENG%20SmPC_09001bee807a3c0c.pdf"
}

See everything about glucosamine hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.